Zurueck zur Suche

Reporte zur Charge U022726

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 NJ 1 WI 1

VAERS 2573224

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u022726

gering
Staat
-
Alter
4,0
Geschlecht
F
Eingang
01.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product administration error

Symptomtext

Vaccine admin error: Administered expired Proquad vaccine (had expired within a week before) making the dose invalid, Patient/parent notified and will return to revaccinate with an appropriate dose in 3 months.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282631

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U022726

gering
Staat
NY
Alter
1,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No additional AEs or PQC reported.; Caller reports patient received both VARIVAX and PROQUAD on the same day.; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-MAY-2022, the patient was vaccinated on the same day with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U025791 was confirmed to be valid, expiration date: 19-AUG-2023 (strength not provided), administered for prophylaxis and with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U022726, expiration date: 16-JAN-2023, (strength not provided), administered for prophylaxis (Overdose). No adverse effect was reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2212940

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U022726

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
02.04.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No other AE; 17-year-old patient received a dose of PROQUAD; This spontaneous report was sent by a registered nurse and refers to a 17-year-old patient of an unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 15-MAR-2022, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant Human Albumin) (PROQUAD), 0.5 ml subcutaneously, once, lot number: U022726, expiration date 16-JAN-2023 (dose number and anatomical location were not reported) for prophylaxis (product administered to patient of inappropriate age). No other adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2164881

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U022726

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
08.03.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose Wrong product administered

Symptomtext

The nurse states PROQUAD and VARIVAX was administered to the patient instead of MMR II and VARIVAX; The nurse states PROQUAD and VARIVAX was administered to the patient instead of MMR II and VARIVAX; This spontaneous report was received from a nurse practitioner, referring to a 12-month-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 03-FEB-2022, the patient received therapy with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #U022726, expiration date: 16-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U020239, expiration date: 28-JUN-2023, administered for prophylaxis (strength, and route of administration were not provided). She received those medications instead of Measles and Mumps Virus Vaccine, Live (M-M-R-II) with varicella virus vaccine live (oka/merck) (VARIVAX)(accidental overdose and wrong product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-